Litcius/Paper detail

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort

John Pasi, Toshko Lissitchkov, Vasily Mamonov, Tim Mant, Margarita Timofeeva, Catherine Bagot, Pratima Chowdary, Pencho Georgiev, Liana Gercheva, Kate Madigan, Huy Van Nguyen, Qifeng Yu, Baisong Mei, Craig C Benson, Margaret V. Ragni

2021Journal of Thrombosis and Haemostasis104 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdverse effectAntithrombinHaemophiliaQuality of life (healthcare)Internal medicineHemostasisPharmacodynamicsFactor IXPharmacokineticsCohortGastroenterologySurgeryHeparinNursingHemophilia Treatment and ResearchBlood Coagulation and Thrombosis MechanismsCoagulation, Bradykinin, Polyphosphates, and Angioedema
Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort | Litcius